Boardroom Alpha
Boardroom Alpha
APOG · Additional Proxy Materials (DEFA14A) · Filed May 12, 2026

Apogee Enterprises Inc — Additional Proxy Materials (DEFA14A)

Form
DEFA14A
Filed
May 12, 2026
Ticker
APOG
Accession
0000006845-26-000034
Boardroom Alpha · Filing insights

Apogee Enterprises' board urges shareholders to vote For all items on the June 24, 2026 proxy.

About Apogee Enterprises Inc
Market cap
$819M
1Y TSR
−5.6%
3Y TSR
−3.8%
Board grade
B-
Sector
Basic Materials
CEO
Donald A Nolan
Last annual meeting: Jun 24, 2026 · View full Apogee Enterprises Inc profile →
amsnotice
Your Vote Counts! Smartphone users Point your camera here and vote without entering a control number For complete information and to vote, visit www.ProxyVote.com Control # V87832-P49920 *Please check the meeting materials for any special requirements for meeting attendance. APOGEE ENTERPRISES, INC. APOGEE ENTERPRISES, INC. 4400 WEST 78TH STREET SUITE 520 MINNEAPOLIS, MN 55435 2026 Annual Meeting Vote by June 23, 2026 11:59 PM ET. For shares held in a plan, vote by June 22, 2026 12:00 PM ET. You invested in APOGEE ENTERPRISES, INC. and it’s time to vote! You have the right to vote on proposals being presented at the Annual Meeting. This is an important notice regarding the availability of proxy materials for the shareholder meeting to be held on June 24, 2026 at 8:00 A.M. Central Time. Get informed before you vote View the Notice and Proxy Statement and Annual Report online OR you can receive a free paper or email copy of the material(s) by requesting prior to June 10, 2026. If you would like to request a copy of the material(s) for this and/or future shareholder meetings, you may (1) visit www.ProxyVote.com, (2) call 1-800-579-1639 or (3) send an email to sendmaterial@proxyvote.com. If sending an email, please include your control number (indicated below) in the subject line. Unless requested, you will not otherwise receive a paper or email copy. Vote Virtually at the Meeting* June 24, 2026 8:00 AM, CT Virtually at: www.virtualshareholdermeeting.com/APOG2026


 
Vote at www.ProxyVote.com Voting Items Board Recommends V87833-P49920 THIS IS NOT A VOTABLE BALLOT This is an overview of the more complete proxy materials, which contain important information and are available on the internet, or by email or mail. Please follow the instructions on the reverse side to view these materials and to vote. Prefer to receive an email instead? While voting on www.ProxyVote.com, be sure to click “Delivery Settings”. 1. ELECTION OF DIRECTORS: Nominees: Class I Directors 1a. Donald A. Nolan For 1b. Patricia K. Wagner For 2. ADVISORY VOTE TO APPROVE APOGEE’S EXECUTIVE COMPENSATION. For 3. APPROVAL OF THE APOGEE ENTERPRISES, INC. 2019 STOCK INCENTIVE PLAN, AS AMENDED AND RESTATED (2026) TO INCREASE THE NUMBER OF SHARES AUTHORIZED FOR AWARDS FROM 2,150,000 TO 2,950,000. For 4. ADVISORY VOTE TO RATIFY THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING FEBRUARY 27, 2027. For 5. In their discretion, the Proxies are authorized to vote upon such other business as may properly be brought before the meeting.


 
From this filing to the vote

Forecast every director vote the day the proxy files.

Meeting Forecast scores each director up for re-election + every contested situation, rebuilt daily across 6,000+ U.S. public companies. The same model that called the LULU contested proxy lives on every meeting you see here.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Apogee Enterprises Inc (APOG)

Reference

Frequently asked questions

When did Apogee Enterprises Inc file this DEFA14A?
Apogee Enterprises Inc (APOG) filed this Additional Proxy Materials (DEFA14A) with the SEC on May 12, 2026. The accession number assigned by EDGAR is 0000006845-26-000034.
What does a DEFA14A disclose?
DEFA14A is additional definitive proxy soliciting material filed in connection with a shareholder meeting — supplemental letters, slides, or amendments issued after the main proxy statement.
What is the key takeaway from this filing?
Apogee Enterprises' board urges shareholders to vote For all items on the June 24, 2026 proxy. This is Boardroom Alpha's one-line summary of the additional proxy materials; see the full filing text above for the formal disclosure.
Where can I find Apogee Enterprises Inc's prior proxy statements on EDGAR?
The SEC EDGAR browser lists every DEFA14A Apogee Enterprises Inc has filed under CIK 6845, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer